Xeris Biopharma Ownership | Who Owns Xeris Biopharma?

Overview Forecast RevenueFinancials Chart Transcripts

Xeris Biopharma Ownership Summary

Xeris Biopharma is owned by 18.83% institutional investors, 3.93% insiders, and 77.24% retail investors. Blackrock is the largest institutional shareholder, holding 7.35% of XERS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.76% of its assets in Xeris Biopharma shares.

XERS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Xeris Biopharma	18.83%	3.93%	77.24%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	10.33M	7.35%	$23.25M
Blackrock funding, inc. /de	10.82M	7.26%	$36.68M
Vanguard group	7.90M	5.30%	$26.78M
State street	3.26M	2.32%	$7.33M
Geode capital management	3.35M	2.25%	$11.36M
Rosalind advisors	3.10M	2.08%	$10.53M
Aigh capital management	2.57M	1.73%	$8.73M
Renaissance	2.10M	1.41%	$7.12M
Caxton	2.02M	1.35%	$6.83M
Millennium management	1.95M	1.31%	$6.61M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Caxton	2.02M	41.06%	$6.83M
Rosalind advisors	3.10M	5.38%	$10.53M
Aigh capital management	2.57M	2.73%	$8.73M
Knott david m jr	1.00M	1.23%	$3.39M
Stonepine capital management	182.32K	0.50%	$618.05K
Essex investment management	474.95K	0.29%	$1.61M
Parkman healthcare partners	578.51K	0.26%	$1.96M
Centerbook partners lp	690.08K	0.14%	$2.34M
Alpine global management	160.00K	0.13%	$542.40K
Eam investors	222.38K	0.11%	$753.86K

Top Buyers

Holder	Shares	% Assets	Change
Ubs group	1.73M	0.00%	1.45M
Goldman sachs group	1.59M	0.00%	754.14K
Jpmorgan chase	1.04M	0.00%	651.48K
Millennium management	1.95M	0.00%	502.85K
Renaissance	2.10M	0.01%	500.12K

Top Sellers

Holder	Shares	% Assets	Change
Bioimpact capital	-	-	-4.83M
Caxton	2.02M	41.06%	-3.10M
Centerbook partners lp	690.08K	0.14%	-2.79M
Walleye capital	-	-	-1.12M
Redmile group	451.10K	0.11%	-595.49K

New Positions

Holder	Shares	% Assets	Change	Value
Essex investment management	474.95K	0.29%	474.95K	$1.61M
Eam investors	222.38K	0.11%	222.38K	$753.86K
Stonepine capital management	182.32K	0.50%	182.32K	$618.05K
Legato capital management	142.16K	0.06%	142.16K	$481.94K
Globeflex capital l p	125.21K	0.04%	125.21K	$424.46K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-27.00
American capital advisory	-50.00
Soa wealth advisors, llc.	-118.00
Comerica bank	-417.00
Federation des caisses desjardins du quebec	-570.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	68	-53.42%	28,055,641	-56.11%	18	1.02%	34	-53.42%	9	-73.53%
Sep 30, 2024	143	4.38%	63,815,802	5.21%	42	2.30%	71	1.43%	34	-5.56%
Jun 30, 2024	137	-6.16%	60,658,095	0.07%	43	2.32%	70	-17.65%	36	9.09%
Mar 31, 2024	146	19.67%	60,615,681	1.47%	43	2.31%	85	49.12%	33	6.45%
Dec 31, 2023	122	7.02%	59,735,564	8.86%	43	2.74%	57	9.62%	31	19.23%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	4.25M	2.76%	-
Vanguard Total Stock Mkt Idx Inv	4.22M	2.74%	-
iShares Russell 2000 ETF	3.71M	2.41%	-32.12K
Vanguard Institutional Extnd Mkt Idx Tr	2.36M	1.53%	-1.69K
CREF Stock R1	1.48M	0.96%	-
CREF Stock R3	1.48M	0.96%	-
Fidelity Small Cap Index	1.41M	0.92%	-26.41K
iShares Russell 2000 Growth ETF	1.23M	0.80%	-5.85K
State St Russell Sm/Mid Cp® Indx NL Cl C	836.04K	0.54%	-15.70K
State St Russell Sm/Mid Cp® Indx SL Cl I	836.04K	0.54%	-15.70K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 20, 2025	Hecht Beth	See Remarks	Sell	$217.24K
Aug 12, 2024	Schmid John P.	-	Buy	$10.15K
Aug 09, 2024	Schmid John P.	-	Buy	$10.13K
May 10, 2024	Schmid John P.	-	Buy	$10.31K
Mar 14, 2024	Schmid John P.	-	Buy	$9.72K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	1
2024 Q4	-	-
2024 Q3	2	-
2024 Q2	1	-

XERS Ownership FAQ

Who Owns Xeris Biopharma?

Xeris Biopharma shareholders are primarily institutional investors at 18.83%, followed by 3.93% insiders and 77.24% retail investors. The average institutional ownership in Xeris Biopharma's industry, Biotech Stocks , is 68.48%, which Xeris Biopharma falls below.

Who owns the most shares of Xeris Biopharma?

Xeris Biopharma’s largest shareholders are Blackrock (10.33M shares, 7.35%), Blackrock funding, inc. /de (10.82M shares, 7.26%), and Vanguard group (7.9M shares, 5.30%). Together, they hold 19.92% of Xeris Biopharma’s total shares outstanding.

Does Blackrock own Xeris Biopharma?

Yes, BlackRock owns 7.35% of Xeris Biopharma, totaling 10.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 23.25M$. In the last quarter, BlackRock increased its holdings by 371.57K shares, a 3.73% change.

Who is Xeris Biopharma’s biggest shareholder by percentage of total assets invested?

Caxton is Xeris Biopharma’s biggest shareholder by percentage of total assets invested, with 41.06% of its assets in 2.02M Xeris Biopharma shares, valued at 6.83M$.

Who is the top mutual fund holder of Xeris Biopharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Xeris Biopharma shares, with 2.76% of its total shares outstanding invested in 4.25M Xeris Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools